SCNX logo

Scienture Holdings, Inc.

SCNX
Healthcare|Medical - Pharmaceuticals|US
$3.13
+0.03 (+0.81%)
DCF Value
$1.00
Cash / Share
$5.17
Next Earnings Report
Nov 11, 2026
EPS est. -$1.57 · Revenue est. $1.2M
Financing Filings (last 12 months)
0
No shelf registrations or offering prospectuses filed.

Upcoming Data Readouts (0)

No upcoming completion dates found in active trials.

Recent Press Releases

SCIENTURE Issues Shareholder Letter Highlighting Sequential Revenue Growth, Two FDA-Approved Commercial Products, and Continued Progress Toward Profitability in 2027
Oct 22, 2026 · GlobeNewsWire
SCIENTURE Reports Approximately $1.22 Million in Unaudited Preliminary Q3 2026 Revenue, Achieving 256% Sequential Growth
Oct 13, 2026 · GlobeNewsWire
SCIENTURE Announces Arbli™ Added to Formularies at Three Leading U.S. Pediatric Academic Medical Centers and Hospitals
Oct 2, 2026 · GlobeNewsWire
Scienture Holdings, Inc. Announces Reverse Stock Split
Sep 30, 2026 · GlobeNewsWire
SCIENTURE Expands Commercial Reach of REZENOPY™ to Addiction Treatment Centers through an Agreement with a Distribution Partner
Sep 22, 2026 · GlobeNewsWire
SCIENTURE to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14, 2026
Sep 9, 2026 · GlobeNewsWire
SCIENTURE Reports Q2 2026 Results with Approximately 510% Sequential Revenue Growth from Q1 2026 and Significant Improvement in Operating Performance
Aug 14, 2026 · GlobeNewsWire
SCIENTURE Announces Commercial Launch and Fulfillment of Initial Purchase Orders of REZENOPY™, the Highest Dose FDA-Approved Naloxone Nasal Spray
Aug 12, 2026 · GlobeNewsWire

SEC Filings (76)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 3, 20268-KMaterial eventDocumentIndex
Oct 19, 20268-KMaterial eventDocumentIndex
Oct 7, 20268-KMaterial eventDocumentIndex
Sep 18, 2026DEF 14AProxy / shareholder voteDocumentIndex
Sep 14, 20268-KMaterial eventDocumentIndex
Sep 8, 2026PRE 14AProxy / shareholder voteDocumentIndex
Aug 20, 20268-KMaterial eventDocumentIndex
Aug 13, 202610-QQuarterly reportDocumentIndex
May 29, 20268-KMaterial eventDocumentIndex
May 22, 20268-KMaterial eventDocumentIndex
May 15, 202610-QQuarterly reportDocumentIndex
May 5, 20268-KMaterial eventDocumentIndex
May 1, 20268-KMaterial eventDocumentIndex
Apr 30, 202610-K/AAnnual reportDocumentIndex
Mar 30, 202610-KAnnual reportDocumentIndex
Nov 18, 20258-KMaterial eventDocumentIndex
Nov 14, 20258-KMaterial eventDocumentIndex
Nov 14, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Nov 13, 20258-KMaterial eventDocumentIndex
Nov 12, 202510-QQuarterly reportDocumentIndex
Nov 7, 2025424B5Offering prospectusDocumentIndex
Oct 30, 20258-KMaterial eventDocumentIndex
Oct 24, 2025424B5Offering prospectusDocumentIndex
Oct 24, 20258-KMaterial eventDocumentIndex
Oct 24, 2025DEF 14AProxy / shareholder voteDocumentIndex
Oct 17, 20258-KMaterial eventDocumentIndex
Oct 16, 20258-KMaterial eventDocumentIndex
Oct 14, 2025424B3Offering prospectusDocumentIndex
Oct 7, 2025PRE 14AProxy / shareholder voteDocumentIndex
Oct 6, 20258-KMaterial eventDocumentIndex
Oct 3, 20258-KMaterial eventDocumentIndex
Sep 23, 20258-KMaterial eventDocumentIndex
Sep 19, 2025424B5Offering prospectusDocumentIndex
Aug 27, 2025EFFECTDocumentIndex
Aug 27, 2025424B3Offering prospectusDocumentIndex
Aug 25, 2025S-3Shelf registrationDocumentIndex
Aug 20, 2025SC 13GPassive 5%+ stakeDocumentIndex
Aug 19, 2025SC 13GPassive 5%+ stakeDocumentIndex
Aug 15, 20258-KMaterial eventDocumentIndex
Aug 15, 2025424B5Offering prospectusDocumentIndex